Alpha Teknova TKNO
NASDAQ TKNO
$7.36 +0.36 (+5.14%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alpha Teknova (TKNO) Liabilities and Shareholders Equity (2020 - 2026)

Alpha Teknova (TKNO) posted quarterly Liabilities and Shareholders Equity of $98.7 million for Q1 2026, down 13.45% year-over-year from $114.0 million in Q1 2025, and down 4.76% quarter-over-quarter from $103.6 million in Q4 2025.

Alpha Teknova (TKNO) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $98.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 13.45% year-over-year to $98.7 million; the TTM figure through Mar 2026 stood at $420.4 million (down 10.98% YoY), while the FY2025 annual figure was $103.6 million, down 12.79% from the prior year.
  • Liabilities and Shareholders Equity declined to $98.7 million in Q1 2026 per TKNO's latest filing, from $103.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $184.1 million in Q1 2022 and bottomed at $98.7 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $131.3 million across 5 years, with a median of $124.1 million in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity gained 5.58% — and 2023, when it fell 27.25%.
  • Alpha Teknova's Liabilities and Shareholders Equity stood at $152.3 million in 2022, then retreated by 15.55% to $128.6 million in 2023, then declined by 7.64% to $118.8 million in 2024, then dropped by 12.79% to $103.6 million in 2025, then retreated by 4.76% to $98.7 million in 2026.
  • Business Quant data shows TKNO's Liabilities and Shareholders Equity at $98.7 million in Q1 2026, $103.6 million in Q4 2025, and $107.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 39.86 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 6.18 Bn
10 Alpha Teknova 396.90 Mn 379.46 Mn 4.89 Mn 95.88 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 95.88 Mn
Mar 31, 2026 98.66 Mn
Dec 31, 2025 103.58 Mn
Sep 30, 2025 107.63 Mn
Jun 30, 2025 110.49 Mn
Mar 31, 2025 113.99 Mn
Dec 31, 2024 118.77 Mn
Sep 30, 2024 124.10 Mn
Jun 30, 2024 115.35 Mn
Mar 31, 2024 120.82 Mn
Dec 31, 2023 128.59 Mn
Sep 30, 2023 138.39 Mn
Jun 30, 2023 132.55 Mn
Mar 31, 2023 141.02 Mn
Dec 31, 2022 152.26 Mn
Sep 30, 2022 160.27 Mn
Jun 30, 2022 182.20 Mn
Mar 31, 2022 184.08 Mn
Dec 31, 2021 166.51 Mn
Sep 30, 2021 169.16 Mn